Brooklyn Immunotherapeutics Inc.

Brooklyn Immunotherapeutics Inc.

World Rank (Jan-05-2024)
18,926
World Rank (Jul-30-2023)
18,926
World Rank (Jan-07-2022)
18,926
Market Cap (Jan-07-2022)
0.200 Billion USD
Headquarters Country
USA
Market Cap (Mar-08-2026)
1.51
Headquarters City/State
New York
World Region
Americas
World Subregion
Northern America
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
BROOKLYN IMMUNOTHERAPEUTICS, INC.
Company Profile
Brooklyn ImmunoTherapeutics is a Clinical Stage Biopharmaceutical company committed to creating a world where patients and families with high unmet medical needs have access to effective treatments. The company annual revenue is 5.8 million USD. The headquarters is in USA.

Share